Neurocrine Biosciences
NBIX
#1285
Rank
HK$138.58 B
Marketcap
HK$1,378
Share price
0.93%
Change (1 day)
32.89%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Annual Reports

Thumbnail Neurocrine Biosciences
 Annual Report 2025

Annual Report 2025

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2024

Annual Report 2024

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2021

Annual Report 2021

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2020

Annual Report 2020

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2019

Annual Report 2019

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2018

Annual Report 2018

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2017

Annual Report 2017

Language: English

View Annual Report
Thumbnail Neurocrine Biosciences
 Annual Report 2016

Annual Report 2016

Language: English

View Annual Report